These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23845184)

  • 1. Improved prediction of medical expenditures and health care utilization using an updated chronic disease score and claims data.
    Huber CA; Schneeweiss S; Signorell A; Reich O
    J Clin Epidemiol; 2013 Oct; 66(10):1118-27. PubMed ID: 23845184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic, pharmacy-based, and self-reported health measures in risk equalization models.
    Stam PJ; van Vliet RC; van de Ven WP
    Med Care; 2010 May; 48(5):448-57. PubMed ID: 20393368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
    Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
    J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health plan utilization and costs of specialty drugs within 4 chronic conditions.
    Gleason PP; Alexander GC; Starner CI; Ritter ST; Van Houten HK; Gunderson BW; Shah ND
    J Manag Care Pharm; 2013 Sep; 19(7):542-8. PubMed ID: 23964615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future expenditure risk of silent members: a statistical analysis.
    Krause TM; Yay Donderici E; Ganduglia Cazaban C; Franzini L
    BMC Health Serv Res; 2016 Jul; 16():319. PubMed ID: 27473359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flare frequency, healthcare resource utilisation and costs among patients with gout in a managed care setting: a retrospective medical claims-based analysis.
    Jackson R; Shiozawa A; Buysman EK; Altan A; Korrer S; Choi H
    BMJ Open; 2015 Jun; 5(6):e007214. PubMed ID: 26109113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimorbidity, health care utilization and costs in an elderly community-dwelling population: a claims data based observational study.
    Bähler C; Huber CA; Brüngger B; Reich O
    BMC Health Serv Res; 2015 Jan; 15():23. PubMed ID: 25609174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
    Rothbard AB; Lee S; Blank MB
    J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What Contributes Most to High Health Care Costs? Health Care Spending in High Resource Patients.
    Pritchard D; Petrilla A; Hallinan S; Taylor DH; Schabert VF; Dubois RW
    J Manag Care Spec Pharm; 2016 Feb; 22(2):102-9. PubMed ID: 27015249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan.
    Garris C; Jhingran P; Bass D; Engel-Nitz NM; Riedel A; Dennis G
    J Med Econ; 2013; 16(5):667-77. PubMed ID: 23425294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of nonreferral outpatient co-payment on medical care utilization and expenditures in Taiwan.
    Chen LC; Schafheutle EI; Noyce PR
    Res Social Adm Pharm; 2009 Sep; 5(3):211-24. PubMed ID: 19733822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease-related and all-cause health care costs of elderly patients with gout.
    Wu EQ; Patel PA; Yu AP; Mody RR; Cahill KE; Tang J; Krishnan E
    J Manag Care Pharm; 2008 Mar; 14(2):164-75. PubMed ID: 18331118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share.
    Cecil WT; Barnes J; Shea T; Coulter SL
    J Manag Care Pharm; 2006 Oct; 12(8):665-76. PubMed ID: 17269845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription drug costs and the generic dispensing ratio.
    Liberman JN; Roebuck MC
    J Manag Care Pharm; 2010 Sep; 16(7):502-6. PubMed ID: 20726679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician drug dispensing in Switzerland: association on health care expenditures and utilization.
    Trottmann M; Frueh M; Telser H; Reich O
    BMC Health Serv Res; 2016 Jul; 16():238. PubMed ID: 27391118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a Novel Cost-Saving Pharmacy Program on Pregabalin Use and Health Care Costs.
    Martin C; Odell K; Cappelleri JC; Bancroft T; Halpern R; Sadosky A
    J Manag Care Spec Pharm; 2016 Feb; 22(2):132-44. PubMed ID: 27015252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of satisfaction: a national study of patient satisfaction, health care utilization, expenditures, and mortality.
    Fenton JJ; Jerant AF; Bertakis KD; Franks P
    Arch Intern Med; 2012 Mar; 172(5):405-11. PubMed ID: 22331982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity prevalence, healthcare utilization, and expenditures of Medicaid enrolled adults with autism spectrum disorders.
    Vohra R; Madhavan S; Sambamoorthi U
    Autism; 2017 Nov; 21(8):995-1009. PubMed ID: 27875247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The performance of administrative and self-reported measures for risk adjustment of Veterans Affairs expenditures.
    Maciejewski ML; Liu CF; Derleth A; McDonell M; Anderson S; Fihn SD
    Health Serv Res; 2005 Jun; 40(3):887-904. PubMed ID: 15960696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.